These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35056427)
1. Algorithms with Area under the Curve for Daily Urinary Estrone-3-Glucuronide and Pregnanediol-3-Glucuronide to Signal the Transition to the Luteal Phase. Usala SJ; Alliende ME; Trindade AA Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056427 [No Abstract] [Full Text] [Related]
2. Comparison of Day-Specific Serum LH, Estradiol, and Progesterone with Mira Usala SJ; Vineyard DD; Kastis M; Trindade AA; Gill HS Medicina (Kaunas); 2024 Jul; 60(8):. PubMed ID: 39202489 [No Abstract] [Full Text] [Related]
3. The Fertility Indicator Equation Using Serum Progesterone and Urinary Pregnanediol-3-Glucuronide for Assessment of Ovulatory to Luteal Phase Transition. Usala SJ; Alliende ME; Trindade AA Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33546226 [No Abstract] [Full Text] [Related]
4. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles. Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744 [TBL] [Abstract][Full Text] [Related]
5. Validation of urinary reproductive hormone measurements using a novel smartphone connected reader. Pattnaik S; Das D; Venkatesan VA Sci Rep; 2023 Jun; 13(1):9227. PubMed ID: 37286704 [TBL] [Abstract][Full Text] [Related]
6. The prediction and/or detection of ovulation by means of urinary steroid assays. Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775 [TBL] [Abstract][Full Text] [Related]
7. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays. Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896 [TBL] [Abstract][Full Text] [Related]
8. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period. Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961 [TBL] [Abstract][Full Text] [Related]
9. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing. Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389 [TBL] [Abstract][Full Text] [Related]
10. Pilot Evaluation of a New Urine Progesterone Test to Confirm Ovulation in Women Using a Fertility Monitor. Bouchard TP; Fehring RJ; Schneider M Front Public Health; 2019; 7():184. PubMed ID: 31312631 [No Abstract] [Full Text] [Related]
11. Identification of anovulation and transient luteal function using a urinary pregnanediol-3-glucuronide ratio algorithm. Kassam A; Overstreet JW; Snow-Harter C; De Souza MJ; Gold EB; Lasley BL Environ Health Perspect; 1996 Apr; 104(4):408-13. PubMed ID: 8732951 [TBL] [Abstract][Full Text] [Related]
12. Use of urinary pregnanediol 3-glucuronide to confirm ovulation. Ecochard R; Leiva R; Bouchard T; Boehringer H; Direito A; Mariani A; Fehring R Steroids; 2013 Oct; 78(10):1035-40. PubMed ID: 23831784 [TBL] [Abstract][Full Text] [Related]
13. Distinct urinary progesterone metabolite profiles during the luteal phase. Abdullah S; Bouchard T; Leiva R; Boehringer H; Iwaz J; Ecochard R Horm Mol Biol Clin Investig; 2023 Jun; 44(2):137-144. PubMed ID: 36578213 [TBL] [Abstract][Full Text] [Related]
14. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women. Direito A; Bailly S; Mariani A; Ecochard R Fertil Steril; 2013 Jan; 99(1):279-285.e3. PubMed ID: 22999798 [TBL] [Abstract][Full Text] [Related]
15. Origins and consequences of the elongation of the human menstrual cycle during the menopausal transition: the FREEDOM Study. Miro F; Parker SW; Aspinall LJ; Coley J; Perry PW; Ellis JE; J Clin Endocrinol Metab; 2004 Oct; 89(10):4910-5. PubMed ID: 15472184 [TBL] [Abstract][Full Text] [Related]
16. Partial recovery of luteal function after bariatric surgery in obese women. Rochester D; Jain A; Polotsky AJ; Polotsky H; Gibbs K; Isaac B; Zeitlian G; Hickmon C; Feng S; Santoro N Fertil Steril; 2009 Oct; 92(4):1410-1415. PubMed ID: 18829008 [TBL] [Abstract][Full Text] [Related]
17. Hormonal Predictors of Abnormal Luteal Phases in Normally Cycling Women. Abdulla SH; Bouchard TP; Leiva RA; Boyle P; Iwaz J; Ecochard R Front Public Health; 2018; 6():144. PubMed ID: 29881719 [No Abstract] [Full Text] [Related]
18. Use of the Home Ovarian Monitor in pregnancy avoidance. Brown JB; Holmes J; Barker G Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460 [TBL] [Abstract][Full Text] [Related]
19. Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites. Dahl KD; Czekala NM; Lim P; Hsueh AJ J Clin Endocrinol Metab; 1987 Mar; 64(3):486-93. PubMed ID: 3102537 [TBL] [Abstract][Full Text] [Related]
20. Mean versus individual hormonal profiles in the menstrual cycle. Alliende ME Fertil Steril; 2002 Jul; 78(1):90-5. PubMed ID: 12095496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]